Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.970
+0.110 (2.26%)
Feb 6, 2026, 4:00 PM EST - Market closed
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $52.18 million as of February 9, 2026. Its market cap has increased by 32.11% in one year.
Market Cap
52.18M
Enterprise Value
30.42M
1-Year Change
32.11%
Ranking
Category
Stock Price
$4.97
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $52.18M, a decrease of -28.38%. That is a compound annual growth rate of -7.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 52.18M | -11.72% |
| Dec 31, 2025 | 59.10M | 81.41% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
| Nov 25, 2021 | 72.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tevogen Bio Holdings | 56.45M |
| InflaRx | 55.92M |
| Estrella Immunopharma | 55.49M |
| Liminatus Pharma | 55.48M |
| ImmuCell | 55.25M |
| PMV Pharmaceuticals | 54.28M |
| Grace Therapeutics | 53.85M |
| Entera Bio | 53.65M |